HealthEU Medicines Panel Recommends Zybrivo for Some First-Line Lung Cancer PatientsBy Naomi CalderNov 16, 2026, 12:20 AM UTC
HealthPhase 3 Trial Reports Longer Survival With Arcotatug TavatecanBy Naomi CalderOct 23, 2026, 8:39 PM UTC